California Court of Appeal Affirms that Federal Impossibility Preemption Defeats Prop 65 Warning Claims for Over-the-Counter Generic Ranitidine

The manufacturers and retailers of over-the-counter generic Zantac (ranitidine) have secured an important appellate victory in California state court. On March 9, the San Francisco-based California Court of Appeal, First Division, handed down its reported opinion affirming the Alameda County court’s decision dismissing — as federally preempted — a consumer group’s Proposition 65 claims against generic ranitidine manufacturers and retailers. Ranitidine-containing products were pulled from the…
By: Goodell, DeVries, Leech & Dann, LLP
Previous Story

Linux gets double-quick double-update to fix kernel Oops!

Next Story

Florida Legislature Considers Further Significant Tort Reforms